Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C O Hanemann

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Neuromuscular Disorders : NMD|October 12, 2001
Axon damage in CMT due to mutation in myelin protein P0C O Hanemann, A A Gabreëls-Festen, P De Jonghe
Journal of Neurosurgery|January 1, 1990
Recurrent hematomas following craniotomy for traumatic intracranial massR Bullock, C O Hanemann, L Murray, et al.
Human Molecular Genetics|January 5, 2002
Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosisK M M Schulze, C O Hanemann, H W Müller, et al.
Neuropathology and Applied Neurobiology|January 13, 2012
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's diseaseC B Carroll, M-L Zeissler, C O Hanemann, et al.
Glia|February 2, 2008
Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cellsC Flaiz, T Utermark, D B Parkinson, et al.
Brain : a Journal of Neurology|October 1, 1996
Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stagesC O Hanemann, A A Gabreëls-Fasten, H W Müller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 19, 2009
Acquired rippling muscle disease in association with myasthenia gravisJ S George, S Harikrishnan, I Ali, et al.
Brain : a Journal of Neurology|April 25, 2000
Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1AC O Hanemann, D D'Urso, A A Gabreëls-Festen, et al.
Acta Neuropathologica|October 28, 1997
Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbsC O Hanemann, A A Gabreëls-Festen, G Stoll, et al.
Neuroradiology|January 1, 1993
Balo's concentric sclerosis followed by MRI and positron emission tomographyC O Hanemann, A Kleinschmidt, G Reifenberger, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Neuromuscular Disorders : NMD|October 12, 2001
Axon damage in CMT due to mutation in myelin protein P0C O Hanemann, A A Gabreëls-Festen, P De Jonghe
Journal of Neurosurgery|January 1, 1990
Recurrent hematomas following craniotomy for traumatic intracranial massR Bullock, C O Hanemann, L Murray, et al.
Human Molecular Genetics|January 5, 2002
Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosisK M M Schulze, C O Hanemann, H W Müller, et al.
Neuropathology and Applied Neurobiology|January 13, 2012
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's diseaseC B Carroll, M-L Zeissler, C O Hanemann, et al.
Glia|February 2, 2008
Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cellsC Flaiz, T Utermark, D B Parkinson, et al.
Brain : a Journal of Neurology|October 1, 1996
Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stagesC O Hanemann, A A Gabreëls-Fasten, H W Müller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 19, 2009
Acquired rippling muscle disease in association with myasthenia gravisJ S George, S Harikrishnan, I Ali, et al.
Brain : a Journal of Neurology|April 25, 2000
Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1AC O Hanemann, D D'Urso, A A Gabreëls-Festen, et al.
Acta Neuropathologica|October 28, 1997
Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbsC O Hanemann, A A Gabreëls-Festen, G Stoll, et al.
Neuroradiology|January 1, 1993
Balo's concentric sclerosis followed by MRI and positron emission tomographyC O Hanemann, A Kleinschmidt, G Reifenberger, et al.
Pageof 6